Woodard & Company Asset Management Group’s GSK GSK Stock Holding History

Woodard & Company Asset Management Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-400	Closed	-$20K	–	103
2018 Q3	$20K	Hold	400	–	–	0.02%	126
2018 Q2	$20.2K	Hold	400	–	–	0.02%	117
2018 Q1	$20K	Hold	400	–	–	0.02%	119
2017 Q4	$18K	Buy	+400	New	+$18.5K	0.02%	144

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Woodard & Company Asset Management Group's GSK Position: Q4 2018 in Review

Woodard & Company Asset Management Group sold out of GSK (GSK) in Q4 2018, closing a stake of 400 shares — an estimated $20K sold.

Woodard & Company Asset Management Group first reported a position in GSK in Q4 2017 and held it in 4 quarters. The position peaked at $20.2K in Q2 2018. 800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Woodard & Company Asset Management Group reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Woodard & Company Asset Management Group sold 400 GSK shares in Q4 2018, an estimated $20K.
Woodard & Company Asset Management Group first reported a position in GSK in Q4 2017 and held it in 4 quarters.
Woodard & Company Asset Management Group's GSK position peaked at $20.2K in Q2 2018.
800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Woodard & Company Asset Management Group's 13F filing for Q4 2018, filed 1 Feb 2019.